The USU-4DBio³ Center for Biotechnology, derived from the 4DBio³ Program and administered by Geneva, was established originally as a five-year program with funding by the Defense Health Program to ensure that warfighters are equipped and supported with the latest advancements in biotechnology. The USU-4DBio³ Center for Biotechnology promotes the development and application of advanced bioprinting, biofabrication, and biomanufacturing technologies for research pursuant to Department of Defense priorities and ultimately for translation to clinical medical defense care and training solutions.
The program is based at the Uniformed Services University (USU) on America’s Medical Campus in Bethesda, Maryland and represents a collaboration between USU, Geneva, the Naval Research Laboratory, and Walter Reed National Military Medical Center. USU-4DBio³ includes a 10,000 sq. ft. multi-tool facility and supports a broad array of research and education applications. This facility includes a biofabrication suite, tissue culture room, bioreactor and sensor facility, and medical/surgical simulation room.
The capabilities present allow for military medical applications and translations to the fields of precision medicine, biomarker discovery, drug and vaccine development, medical technology validation, bio-sensors, environmental and occupational health, and regenerative medicine.